The intersection of digital health and artificial intelligence: Clearing the cloud of uncertainty
The Intersection of Digital Health and Artificial Intelligence Quality HTA is pleased to announce the article "The Intersection of Digital Health and Artificial Intelligence: Clearing the Cloud of Uncertainty", written by Pooyeh Grail and [...]
Integration of RWE from Different Sources in HTA
Integration of RWE in HTA - Quality HTA is pleased to announce the article "Integration of Real-world Evidence from Different Data Sources in Health Technology Assessment", written by Pooyeh Grail, Jason R. Guertin, Kelvin [...]
Quality HTA at IEEE 2023
Digital Health & Health Technology Assessment - Quality HTA is honoured to present "Digital Health and Health Technology Assessment" by Pooyeh Graili, the Founder and Principal at Quality HTA. This one-hour talk will be [...]
Conditional Funding Recommendations in Canada
Conditional Funding Recommendations - Quality HTA is pleased to announce its recent paper "Conditional Funding Recommendations for Drugs in Canada: A Cross-Sectional Analysis" written by Pooyeh Grail and published online by Applied Health Economics [...]
The Canadian Trends in Drug Purchase and Projection for 2023
The Canadian Trends in Drug Purchase - The drug purchase in 2021 was 8.3% (around $35.4 billion) higher than in 2020! Dr. Mina Tadrous et. al. estimated pharmaceutical drug purchases across Canada using IQVIA [...]
Quality HTA at the EU ISPOR 2022
Quality HTA at the EU ISPOR 2022 - Quality HTA is pleased to announce the presentation of “Conditional Recommendations by the Canadian Agency for Drugs and Technologies in Health (CADTH)” at the ISPOR Conference [...]
Quality HTA at CAPT-ACTP 2022
CAPT-ACTP Conference 2022 - Quality HTA is pleased to announce the presentation of "Change and Trends in Conditional Recommendations; Analysis of CADTH Reports" at CAPT Conference 2022. This poster will be presented on Monday [...]
The CADTH Post-Market Drug Evaluation Program
The CADTH Post-Market Drug Program - CADTH has launched its Post-Market Evaluation Program to address the uncertainties around the appropriate use of drugs, their long-term safety, and effectiveness after use in the real world. [...]
Where are we in RWE?
Where are we in RWE? - The best relevant RWD source needs to be decided depending on the research question. However, we still need some standard RWE frameworks, particularly when it comes to the [...]
Artificial Intelligence in Health Technology Assessment
Artificial Intelligence (AI) in Health Technology Assessment (HTA) - An hour presentation, AI in HTA, including the Q&A session, presented by Pooyeh Graili at ValleyML virtual meeting on October 12, 2021, is now publicly [...]